Effectiveness and safety of vedolizumab in anti-TNF naive patients with inflammatory bowel disease: a multicentre retrospective European Crohn's and Colitis Organisation study

Kopylov U;Verstockt B;Biedermann L;Sebastian S;Pugliese D;Sonnenberg E;Steinhagen PR;Arebi N;Ron Y;Kucharzik T;Roblin X;Ungar B;Shitrit ABG;Ardizzone S;Molander P;Coletta M;Peyrin-Biroulet L;Bossuyt P;Avni-Biron I;Tsoukal EI;Allocca M;Katsanos K;Raine T;Sipponen T;Fiorino G;Ben-Horin S;Eliakim R;Armuzzi A;Siegmund B;Baumgart DC;Kamperidis N;Maharshak N;Maaser C;Mantzaris G;Yanai H;Christodoulou D;Dotan I;Ferrante M

2018-01-01